← Insider buys
ITCI

Intra-Cellular Therapies, Inc.

EVP and Chief Medical Officer Suresh K. Durgam sold $4.4M of Intra-Cellular Therapies, Inc.

Sold$4,397,113
$70.60Price
62,282Shares
−100%Stake

What ITCI did after the filing

Prices for ITCI after this filing aren't in yet.

Traded Tue, Jan 2. Filed Thu, Jan 4, 2:54 PM ET, during the session. Not investment advice.